子宮內(nèi)膜異位癥診治的新進(jìn)展
[Abstract]:Endometriosis is a common gynecological disease in women of childbearing age. Although endometriosis is a benign disease, it has the ability of invasiveness and adhesion to malignant tumor. The pathogenesis of endometriosis is not very clear. There are different stages in endometriosis. Up to now, the clinical use of rAFS scoring method, but this staging method has shortcomings, there is no satisfactory staging method, In this paper, we summarize the staging methods of endodysm from the first stage proposed by Acosta in 1973 to the present period in which rAFS is widely used in clinical practice, in order to understand the development of the stage of endometriosis and the advantages and disadvantages of each stage. We hope to get enlightenment, perfect the stages of endometriosis, so as to understand the disease in all aspects, and make a scientific and reasonable treatment plan. There are many diagnostic methods for endometriosis. At present, it is considered that laparoscopy is the golden standard for the diagnosis of endometriosis, but the cost of laparoscopic surgery is high, there is trauma, and it is necessary to find a non-invasive, simple and accurate diagnosis method for the operator. In this paper, the types of laparoscopy, new laboratory methods and instrumentation are compared in order to obtain a scientific and convenient diagnostic method by weighing the advantages and disadvantages. The treatment of endometriosis mainly depends on the combination of surgery and postoperative drugs. Laparoscopic surgery is the first choice in the treatment of endometriosis, conservative surgery is the most commonly used operation, and there are many kinds of drugs after operation. Currently, gonadotropin releasing hormone agonists are the most commonly used. The purpose of this paper is to evaluate the advantages and disadvantages of various therapeutic methods in order to find out the treatment scheme which is simple in operation, small in recurrence and small in side effects.
【學(xué)位授予單位】:蘇州大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2014
【分類號】:R711.71
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 茹潔紅,陳亞萍,曹時(shí)珍,許金玉;芳香化酶P450在子宮內(nèi)膜異位癥中的表達(dá)及意義[J];中國婦產(chǎn)科臨床雜志;2004年01期
2 李云霞;徐琳;蘇玉林;;ROC曲線評價(jià)3項(xiàng)標(biāo)記物診斷子宮內(nèi)膜異位癥的價(jià)值[J];國際婦產(chǎn)科學(xué)雜志;2010年02期
3 張清;洛若愚;徐翊;李華;黃鸝;;血清CA19-9及CA125測定診斷子宮內(nèi)膜異位癥[J];國際婦產(chǎn)科學(xué)雜志;2012年02期
4 程云霞;錢志紅;;血清血管內(nèi)皮細(xì)胞生長因子和超敏C反應(yīng)蛋白在子宮內(nèi)膜異位癥中的診斷及治療價(jià)值[J];蘇州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2012年02期
5 劉曼華;邱君君;陳麗平;劉穎蕾;張忠新;劉宏斌;;超聲檢測卵巢子宮內(nèi)膜異位囊腫間質(zhì)血流變化的預(yù)測價(jià)值[J];實(shí)用婦產(chǎn)科雜志;2011年07期
6 段社教;申延琴;郭軍紅;;保守性手術(shù)后服用小劑量米非司酮治療中重度子宮內(nèi)膜異位癥的臨床觀察[J];中國婦幼保健;2006年06期
7 張磊;趙曉嵐;劉瑾;;抗子宮內(nèi)膜抗體、抗精子抗體與子宮內(nèi)膜異位癥關(guān)系的研究[J];中國婦幼保健;2010年28期
8 羅安娜;關(guān)婷;;骨橋蛋白在子宮內(nèi)膜異位癥的表達(dá)及意義[J];中國婦幼保健;2011年27期
9 黃靜;效映霞;;血清CA125和EMAb水平與子宮內(nèi)膜異位癥相關(guān)性的探討[J];中國婦幼保健;2012年18期
10 李莉;陳虹;;彩色多普勒超聲對子宮腺肌癥50例診斷價(jià)值分析[J];中國誤診學(xué)雜志;2008年10期
本文編號:2224078
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/2224078.html